JP2629000B2
(en)
*
|
1986-07-18 |
1997-07-09 |
中外製薬株式会社 |
Stable granulocyte colony stimulating factor-containing preparation
|
JP2628961B2
(en)
*
|
1986-12-23 |
1997-07-09 |
協和醗酵工業株式会社 |
Novel polypeptide
|
CA2736981A1
(en)
|
1998-04-14 |
1999-10-21 |
Kyowa Hakko Bio Co., Ltd. |
Process for producing isoprenoid compounds by microorganisms
|
JP4474496B2
(en)
|
1998-06-02 |
2010-06-02 |
学校法人日本大学 |
IgA nephropathy-related DNA
|
EA013224B1
(en)
|
2000-10-06 |
2010-04-30 |
Киова Хакко Кирин Ко., Лтд. |
Cells producing antibody compositions
|
CN100400660C
(en)
|
2002-12-26 |
2008-07-09 |
协和发酵工业株式会社 |
Method for producing dipeptides
|
US20110189233A1
(en)
|
2004-03-05 |
2011-08-04 |
Kazuhiro Nagaike |
Recombinant Varicella-Zoster Virus
|
JP4705026B2
(en)
|
2004-03-19 |
2011-06-22 |
ジェノミディア株式会社 |
Vascular endothelial growth promoting gene
|
JP3996627B2
(en)
|
2004-07-22 |
2007-10-24 |
エーザイ・アール・アンド・ディー・マネジメント株式会社 |
Lrp4 / Corin dopaminergic neuron progenitor cell marker
|
EP1930344A4
(en)
|
2005-09-29 |
2008-12-31 |
Shionogi & Co |
Polypeptide having anti-angiogenic activity
|
EP2471937A3
(en)
|
2005-11-24 |
2013-04-24 |
The Research Foundation for Microbial Diseases of Osaka University |
Recombinant polyvalent vaccine
|
WO2007063866A1
(en)
|
2005-11-29 |
2007-06-07 |
Kyowa Hakko Kogyo Co., Ltd. |
Novel protein and dna encoding the protein
|
WO2007066698A1
(en)
|
2005-12-06 |
2007-06-14 |
Kyowa Hakko Kogyo Co., Ltd. |
Genetically recombinant anti-perp antibody
|
JP5242382B2
(en)
|
2006-04-14 |
2013-07-24 |
株式会社医学生物学研究所 |
Polypeptide variant having effector function
|
AU2007257646B2
(en)
|
2006-06-06 |
2011-08-11 |
Kyowa Hakko Kirin Co., Ltd. |
Monoclonal antibody capable of binding to heparin-binding epidermal growth factor-like growth factor
|
WO2008038613A1
(en)
|
2006-09-25 |
2008-04-03 |
Kyowa Hakko Bio Co., Ltd. |
Method for production of dipeptide
|
US20110236374A1
(en)
|
2007-01-24 |
2011-09-29 |
Kyowa Hakko Kirin Co., Ltd. |
Genetically recombinant antibody composition capable of binding specifically to ganglioside gm2
|
CA2676529C
(en)
|
2007-01-24 |
2014-03-25 |
Kyowa Hakko Kirin Co., Ltd. |
Genetically recombinant antibody composition having enhanced effector activity
|
US20100075343A1
(en)
|
2007-01-25 |
2010-03-25 |
Motoo Yamasaki |
Novel peptides
|
EP2138576A4
(en)
|
2007-03-16 |
2011-02-23 |
Kyowa Hakko Kirin Co Ltd |
Anti-claudin-4 antibody
|
WO2008123308A1
(en)
|
2007-03-29 |
2008-10-16 |
National University Corporation Okayama University |
Therapeutic agent comprising vasohibin
|
CN101878306A
(en)
|
2007-09-27 |
2010-11-03 |
盐野义制药株式会社 |
Method for producing hydroxylated adamantane using cytochrome P450
|
WO2009054435A1
(en)
|
2007-10-24 |
2009-04-30 |
Otsuka Chemical Co., Ltd. |
Polypeptide having enhanced effector function
|
CN101978054B
(en)
|
2007-12-05 |
2013-05-29 |
协和发酵麒麟株式会社 |
Monoclonal antibody capable of binding to heparin-binding epidermal growth factor-like growth factor
|
CN102007147B
(en)
|
2008-06-30 |
2014-11-05 |
协和发酵麒麟株式会社 |
Anti-CD27 antibody
|
CN103172735B
(en)
|
2008-07-17 |
2014-12-10 |
协和发酵麒麟株式会社 |
Anti-system asc amino acid transporter 2 (asct2) antibody
|
WO2010018847A1
(en)
|
2008-08-13 |
2010-02-18 |
協和発酵キリン株式会社 |
Recombinant protein-s composition
|
WO2010074266A1
(en)
|
2008-12-26 |
2010-07-01 |
協和発酵キリン株式会社 |
Anti-cd4 antibody
|
NZ595825A
(en)
|
2009-04-20 |
2012-10-26 |
Kyowa Hakko Kirin Co Ltd |
Antibody containing igg2 having amino acid mutation introduced therein
|
KR20120110141A
(en)
|
2009-12-28 |
2012-10-09 |
교와 핫꼬 기린 가부시키가이샤 |
Anti-iga1 antibody
|
AU2011222012C1
(en)
|
2010-03-02 |
2015-02-26 |
Kyowa Kirin Co., Ltd. |
Modified antibody composition
|
ES2682078T3
(en)
|
2010-06-11 |
2018-09-18 |
Kyowa Hakko Kirin Co., Ltd. |
Anti-TIM-3 antibody
|
JP5058332B2
(en)
|
2010-07-14 |
2012-10-24 |
住友ゴム工業株式会社 |
Isoprene oligomer, polyisoprene, and production methods thereof, rubber composition, and pneumatic tire
|
CN103781800A
(en)
|
2011-06-20 |
2014-05-07 |
协和发酵麒麟株式会社 |
Anti-erbB3 antibody
|
CN104411720B
(en)
|
2012-07-02 |
2018-05-11 |
协和发酵麒麟株式会社 |
Therapeutic agent using anti-BMP9 antibody as active ingredient, to anaemias such as renal anemia, cancer-related anemias
|
US9714291B2
(en)
|
2012-10-05 |
2017-07-25 |
Kyowa Hakko Kirin Co., Ltd |
Heterodimer protein composition
|
KR20150094617A
(en)
|
2012-12-07 |
2015-08-19 |
교와 핫꼬 기린 가부시키가이샤 |
Anti-folr1 antibody
|
US9944970B2
(en)
|
2013-07-09 |
2018-04-17 |
Kyowa Medex Co., Ltd. |
Glycated hexapeptide oxidase and use thereof
|
EP3653713A4
(en)
|
2017-07-13 |
2021-03-31 |
Kyowa Kirin Co., Ltd. |
ANTI-BRIL ANTIBODIES AND PROCEDURE FOR STABILIZING THE BRIL FUSION PROTEIN WITH THIS ANTIBODY
|
TW201908341A
(en)
|
2017-07-18 |
2019-03-01 |
日商協和醱酵麒麟有限公司 |
Anti-human CCR1 monoclonal antibody
|
CA3081854A1
(en)
|
2017-11-08 |
2019-05-16 |
Kyowa Kirin Co., Ltd. |
Bispecific antibody which binds to cd40 and epcam
|
WO2019117208A1
(en)
|
2017-12-12 |
2019-06-20 |
協和発酵キリン株式会社 |
Anti-bmp10 antibody, and therapeutic agent for hypertension and hypertensive diseases comprising said antibody as active ingredient
|
KR20210025023A
(en)
|
2018-06-26 |
2021-03-08 |
쿄와 기린 가부시키가이샤 |
Antibodies that bind to chondroitin sulfate proteoglycan-5
|
JP7397445B2
(en)
|
2018-06-26 |
2023-12-13 |
協和キリン株式会社 |
Antibody that binds to Cell Adhesion Molecule 3
|
TW202028467A
(en)
|
2018-09-28 |
2020-08-01 |
日商協和麒麟股份有限公司 |
Antibody composition
|
MX2021007797A
(en)
|
2018-12-28 |
2021-10-26 |
Kyowa Kirin Co Ltd |
BISPECIFIC ANTIBODY BINDING TO TfR.
|
US20220220216A1
(en)
|
2019-05-15 |
2022-07-14 |
Kyowa Kirin Co., Ltd. |
Bispecific antibody binding to cd40 and gpc3
|
AU2020276931A1
(en)
|
2019-05-15 |
2021-12-16 |
Kyowa Kirin Co., Ltd. |
Bispecific antibody binding to CD40 and FAP
|
AU2020346580A1
(en)
|
2019-09-13 |
2022-03-31 |
Kyowa Kirin Co., Ltd. |
DcR3 variant
|
US20220380489A1
(en)
|
2019-10-02 |
2022-12-01 |
Kyushu University, National University Corporation |
Method for producing heparin-like substance, recombinant cell, and method for producing the same
|
TW202140561A
(en)
|
2020-02-14 |
2021-11-01 |
日商協和麒麟股份有限公司 |
Bispecific antibody that binds to CD3
|
AU2021249888A1
(en)
|
2020-04-01 |
2022-10-27 |
Kyowa Kirin Co., Ltd. |
Antibody composition
|
CN117836326A
(en)
|
2021-08-26 |
2024-04-05 |
协和麒麟株式会社 |
Bispecific antibodies binding to CD116 and CD131
|
TW202342518A
(en)
|
2022-02-09 |
2023-11-01 |
國立研究開發法人醫藥基盤 健康 營養研究所 |
Antibody or fragment thereof that binds to FCRL1
|